资讯

Flooding of the Baxter manufacturing plant in North Carolina during Hurricane Helene prompted the FDA to declare a shortage for several IV fluid products October 14, 2024 5 min ...
Here are three other shortage updates: Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased ...
Almost 90% of providers are experiencing an IV fluid shortage due to the temporary closure of Baxter's North Carolina plant, according to a survey from group purchasing organization Premier.
Henry Mayo Newhall Hospital is among the hospitals in the United States that are being affected by the IV fluid shortage due ...
Since Baxter is one of Concord's suppliers, it's monitoring the status of IV fluid coming out of their facilities. But Beers adds the pandemic helped them handle emergency situations like these ...
Baxter’s North Cove facility has resumed manufacturing with two production lines now operational, restoring about 50% of its pre-hurricane capacity and 85% of its 1-liter IV solution production.
The shortage is the result of a factory in North Carolina — which is run by the medical supplier Baxter — having been damaged during Hurricane Helene last month. The factory produces about 60% ...
Hurricane Helene knocked out the Baxter International plant in North Carolina that makes about 60 percent of the crucial medical supply, creating a knock-on effect that may persist for a while.
Disruptions from Hurricane Helene exacerbated shortages of critical intravenous fluids in the United States, and now the Biden administration has invoked the wartime powers of the Defense ...
The U.S. government and its agencies are providing recovery assistance and granting import waivers to Baxter International, which makes 60 percent of U.S. IV liquids, after its North Carolina ...
Baxter slowly resumes shipments after Helene, but the pressure of an IV fluid shortage is still on By Katherine Davis Katherine Davis is a former Crain's health care reporter.